Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
+0.15%
IXIC
+0.20%
FTSE
-0.60%
N225
-0.97%
AXJO
-0.41%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
604.65M
Dividend Yield
0.00%
P/E Ratio
1662.62
EPS
0.00
Revenue
384.56M
Avg. Volume
116.03K

Recently from Cashu

publisher logo
Cashu

Knight Therapeutics Secures $50 Million Credit Facility for Growth and Acquisitions

2 months ago
publisher logo
Cashu

Knight Therapeutics Inc. Secures $50 Million Credit Facility for Strategic Growth and Acquisitions

2 months ago
publisher logo
Cashu

Knight Therapeutics Inc. Expands Portfolio with Exclusive Licensing Agreement with Sumitomo Pharma

3 months ago

About

What does GUD.TO do?
Knight Therapeutics, headquartered in Montreal, acquires and commercializes pharmaceutical products, employing 725 staff since its IPO on February 28, 2014. It focuses on developing treatments for neglected tropical and rare pediatric diseases.
Sector
💻 Health Care
IPO
CEO
Employees
745
Headquarters
Website
https://knighttx.comCA/fr/about-us/
Stocks
Health Care
gud.to
Knight Therapeutics Inc
TSX: GUD.TO
-0.06 (-0.92%)
6.48
USD
At close at Aug 26, 17:03 UTC
Summary
News
Signals
Benchmarks
Financials